Background Histone deacetylase (HDAC) inhibitors, developed seeing that promising anti-tumor medications, display their anti-inflammatory properties because of their effects on reduced amount of inflammatory cytokines. of interleukin (IL)-1 and tumor necrosis aspect (TNF)- in bronchoalveolar lavage liquid (BALF) and concentrations of nitric oxide (NO) and myeloperoxidase (MPO) activity in lung tissues homogenates were assessed by… Continue reading Background Histone deacetylase (HDAC) inhibitors, developed seeing that promising anti-tumor medications,